Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: Role of exchange protein activated by cAMP 1 (Epac1)

Journal of Pharmacology and Experimental Therapeutics

Volumn 322, Issue 3, 2007, Pages 1189-1200

  Fang, Ying ^a,c   Olah, Mark E ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b IDAHO STATE UNIVERSITY   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 8 (4 CHLOROPHENYLTHIO) 2' O METHYLADENOSINE 3',5' CYCLIC MONOPHOSPHATE; 8 BROMO CYCLIC AMP; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; EXCHANGE PROTEIN ACTIVATED BY CAMP 1; EXCHANGE PROTEIN ACTIVATED BY CAMP 2; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN DERIVATIVE; PROTEIN KINASE C; RAP1 PROTEIN; RAS PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECEPTOR SENSITIVITY; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSACTIVATION; UMBILICAL VEIN;

CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RECEPTOR, ADENOSINE A2B; RECEPTORS, PURINERGIC P1; UMBILICAL VEINS;

EID: 34548102416     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.119933     Document Type: Article

References (46)

1. Adair TH (2005) Growth regulation of the vascular system: an emerging role for adenosine. Am J Physiol 289:R283-R296.
2. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, and Lawley TJ (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99:683-690.
3. Aird WC (2007) Phenotypic heterogeneity of the endothelium. I. Structure, function, and mechanisms. Circ Res 100:158-173.
4. 2B receptor for 2-(1-hexynyl)adenosine. Mol Pharmacol 58:1349-1356.
5. Chen C, Koh AJ, Datta NS, Zhang J, Keller ET, Xiao G, Franceschi RT, D'Silva NJ, and McCauley LK (2004) Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J Biol Chem 279:29121-29129.
6. Cook SJ and McCormick F (1993) Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1069-1072.
7. Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, and Mayadas TN (2005) Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 105:1950- 1955.
8. de Rooij J, Zwartkruis FJT, Verheijen MHG, Cool RH, Nijman SM, Wittinghofer A, and Bos JL (1998) Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396:474-477.
9. Dhillon AS, Pollock C, Steen H, Shaw PE, Mischak H, and Kolch W (2002) Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol Cell Biol 22:3237-3246.
10. 2B adenosine receptors stimulate growth of porcine and rat arterial endothelial cells. Hypertension 39:530-535.
11. Dugan LL, Kim JS, Zhang Y, Bart RD, Sun Y, Holtzman DM, and Gutmann DH (1999) Differential effects of cAMP in neurons and astrocytes. Role of B-Raf. J Biol Chem 274:25842-25848.
12. Dumaz N and Marais R (2005) Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. FEBS J 272:3491-3504.
13. Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Doskeland SO, Blank JL, and Bos JL (2002) A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 4:901-906.
14. 2B receptors in angiogenic factor regulation. Circ Res 90:531-538.
15. Fujita T, Meguro T, Fukuyama R, Nakamuta H, and Koida M (2002) New signaling pathway for parathyroid hormone and cyclic AMP action on extracellularregulated kinase and cell proliferation in bone cells. Checkpoint of modulation by cyclic AMP. J Biol Chem 277:22191-22200.
16. Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y, Kangawa K, and Mochizuki N (2005) Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 25:136-146.
17. 2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. Cross-talk between cyclic AMP and protein kinase C pathways. J Biol Chem 274:5972-5980.
18. 2B adenosine receptor stimulation. Invest Ophthalmol Vis Sci 42:2068-2073.
19. Grant MB, Tarnuzzer RW, Caballero S, Ozeck MJ, Davis MI, Spoerri PE, Feoktistov I, Biaggioni I, Shryock JC, and Belardinelli L (1999) Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res 85:699-706.
20. Hochbaum D, Tanos T, Ribeiro-Neto F, Altschuler D, and Coso OA (2003) Activation of JNK by Epac is independent of its activity as a Rap guanine nucleotide exchanger. J Biol Chem 278:33738-33746.
21. Holz GG, Kang G, Harbeck M, Roe MW, and Chepurny OG (2006) Cell physiology of cAMP sensor Epac. J Physiol 577:5-15.
22. Iacovelli L, Capobianco L, Salvatore M, Sallese M, D'Ancona GM, and De Blasi A (2001) Thyrotropin activates mitogen-activated protein kinase pathway in RFTL-5 by a cAMP-dependent protein kinase A-independent mechanism. Mol Pharmacol 60:924-933.
23. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, and Graybiel AM (1998) A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275-2279.
24. S-coupled receptors. J Biol Chem 279:46497-46508.
25. 2B adenosine receptors. J Med Chem 43:1165-1172.
26. Kooistra MRH, Corada M, Dejana E, and Bos JL (2005) Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 579:4966-4972.
27. 3 adenosine receptor. J Pharmacol Exp Ther 317:172-180.
28. 7 receptors to activation of extracellular-regulated kinase through a protein kinase A-independent pathway that can utilize Epac. J Neurochem 87:1076-1085.
29. Liu J, Tian Z, Gao B, and Kunos G (2002) Dose-dependent activation of antiapoptotic and proapoptotic pathways by ethanol treatment in human vascular endothelial cells: differential involvement of adenosine. J Biol Chem 277:20927-20933.
30. Luttrell LM (2003) "Location, location, location": activation and targeting of MAP kinases by G protein-coupled receptors. J Mol Endocrinol 30:117-126.
31. Meininger CJ and Granger HJ (1990) Mechanisms leading to adenosine-stimulated proliferation of microvascular endothelial cells. Am J Physiol 258:H198-H206.
32. Mino RP, Spoerri PE, Caballero S, Player D, Belardinelli L, Biaggioni I, and Grant MB (2001) Adenosine receptor antagonists and retinal neovascularization in vivo. Invest Ophthalmol Vis Sci 42:3320-3324.
33. αS-linked) receptors. J Exp Med 186:1615-1620.
34. Moy AB, Blackwell K, Wu MH, and Granger HJ (2006) Growth factor- and heparindependent regulation of constitutive and agonist-mediated human endothelial barrier function. Am J Physiol 291:H2126-H2135.
35. Nguyen DK, Montesinos MC, Williams AJ, Kelly M, and Cronstein BN (2003) Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells. J Immunol 171:3991-3998.
36. Nishihara H, Hwang M, Kizaka-Kondoh S, Eckmann L, and Insel PA (2004) Cyclic AMP promotes cAMP-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1/2 and p38 MAPK. J Biol Chem 279:26176-26183.
37. Pham N, Cheglakov I, Koch CA, de Hoog CL, Moran MF, and Rotin D (2000) The guanine nucleotide exchange factor CNrasGEF activates Ras in response to cAMP and cGMP. Curr Biol 10:555-558.
38. Sands WA, Woolson HD, Milne GR, Rutherford C, and Palmer TM (2006) Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells. Mol Cell Biol 26:6333-6346.
39. Schmitt JM and Stork PJS (2002) Gα and Gβγ require distinct Src-dependent pathways to activate Rap1 and Ras. J Biol Chem 277:43024-43032.
40. 2A-adenosine receptor in primary human endothelial cells. J Biol Chem 272:5792-5799.
41. Stork PJ and Schmitt JM (2002) Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12:258-266.
42. Takahashi H, Honma M, Miyauchi Y, Nakamura S, Ishida-Yamamoto A, and Iizuka H (2004) Cyclic AMP differentially regulates cell proliferation of normal human keratinocytes through ERK activation depending on the expression pattern of B-Raf. Arch Dermatol Res 296:74-82.
43. Wang Z, Dillon TJ, Pokala V, Mishra S, Labudda K, Hunter B, and Stork PJS (2006) Rap1-mediated activation of extracellular signal-regulated kinases by cyclic AMP is dependent on the mode of Rap1 activation. Mol Cell Biol 26:2130-2145.
44. Wittchen ES, Worthylake RA, Kelly P, Casey PJ, Quilliam LA, and Burridge K (2005) Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function. J Biol Chem 280:11675-11682.
45. MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J 16:1584-1594.
46. Zeng H, Sanyal S, and Mukhopadhyay D (2001) Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively. J Biol Chem 276:32714-32719.